Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Natus Medical Inc    BABY

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

Natus Medical : Natus to Present at the Thomas Weisel Partners 2007 Healthcare Conference

share with twitter share with LinkedIn share with facebook
share via e-mail
0
08/28/2007 | 02:00pm CET

Natus Medical Incorporated (Nasdaq:BABY) today announced that Steven J. Murphy, Vice President Finance and Chief Financial Officer of the Company, will make a presentation at the Thomas Weisel Partners 2007 Healthcare Conference. The conference is being held at the Four Seasons Hotel in Boston, Massachusetts. Mr. Murphy is scheduled to present at 2:05 p.m. Eastern Time (11:05 a.m. PT) on Thursday, September 6, 2007.

Investors may listen to the live webcast and view a copy of the slide presentation online via the ?Investors? section of the Company's web site at http://investor.natus.com. The recorded webcast will be accessible online for at least 30 days. Attendance at the Thomas Weisel Partners 2007 Healthcare Conference is by invitation only.

About Natus Medical

Natus is a leading provider of healthcare products used for the screening, detection, treatment, monitoring and tracking of common medical ailments such as hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and newborn care. Product offerings include computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology, as well as newborn care products such as hearing screening systems, phototherapy devices for the treatment of newborn jaundice, head-cooling products for the treatment of brain injury in newborns, and software systems for managing and tracking disorders and diseases for public health laboratories. Additional information about Natus Medical can be found at www.natus.com.

Natus Medical Incorporated
Steven J. Murphy, Chief Financial Officer, 650-802-0400
InvestorRelations@Natus.com


© Business Wire 2007
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on NATUS MEDICAL INC
02/21 NATUS MEDICAL INC : IMPORTANT INVESTOR NOTICE: Khang & Khang LLP Announces Secur..
02/21 NATUS MEDICAL INC : IMPORTANT SHAREHOLDER NOTICE: Lundin Law PC Announces Securi..
02/20 IMPORTANT SHAREHOLDER NOTICE : Lundin Law PC Announces Securities Class Action L..
02/20 Khang & Khang LLP Announces Securities Class Action Lawsuit against Natus Med..
02/20 NATUS MEDICAL INC : Khang & Khang LLP Announces Securities Class Action Lawsuit ..
02/17 NATUS MEDICAL INC : IMPORTANT INVESTOR NOTICE: Lundin Law PC Announces Securitie..
02/16 NATUS MEDICAL INC : Khang & Khang LLP Announces Securities Class Action Lawsuit ..
02/16 NATUS MEDICAL INC : IMPORTANT SHAREHOLDER NOTICE: Lundin Law PC Announces Securi..
02/15 NATUS MEDICAL INC : Khang & Khang LLP Announces Securities Class Action Lawsuit ..
02/15 NATUS MEDICAL INC : Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Cla..
More news
Sector news : Advanced Medical Equipment & Technology - NEC
02/09 Infineon, Cree warn U.S. might block Wolfspeed deal
02/02 EU probes online sales in electronics, video games, hotels
01/31DJTHERMO FISHER SCIENTIFIC : Earnings, Sales Rise
01/31DJDANAHER : Revenue, Profit Rise
01/30DJEUROPEAN MORNING BRIEFING : Corporate Events
More sector news : Advanced Medical Equipment & Technology - NEC
News from SeekingAlpha
02/02 Premarket analyst action - healthcare
02/01 Natus Medical's (BABY) CEO Jim Hawkins on Q4 2016 Results - Earnings Call Tra..
02/01 Natus Medical revenues up 8%; earnings up 20% in Q4; updates Q1 and 2017 guid..
02/01 Natus Medical misses by $0.02, beats on revenue
01/31 Notable earnings before Thursday?s open
Advertisement
Financials ($)
Sales 2017 504 M
EBIT 2017 74,0 M
Net income 2017 50,6 M
Debt 2017 -
Yield 2017 -
P/E ratio 2017 24,82
P/E ratio 2018 18,58
Capi. / Sales 2017 2,47x
Capi. / Sales 2018 2,42x
Capitalization 1 247 M
More Financials
Chart NATUS MEDICAL INC
Duration : Period :
Natus Medical Inc Technical Analysis Chart | BABY | US6390501038 | 4-Traders
Full-screen chart
Technical analysis trends NATUS MEDICAL INC
Short TermMid-TermLong Term
TrendsNeutralBearishNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 4
Average target price 51,0 $
Spread / Average Target 35%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
James B. Hawkins President, Chief Executive Officer & Director
Robert A. Gunst Chairman
Jonathan A. Kennedy Chief Financial Officer, EVP & IR Contact
D. Christopher Chung VP-Medical Affairs, Quality & Regulatory
Doris E. Engibous Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
NATUS MEDICAL INC8.91%1 247
THERMO FISHER SCIENTIF..12.42%62 663
DANAHER CORPORATION8.88%58 622
BOSTON SCIENTIFIC CORP..16.87%34 423
INTUITIVE SURGICAL, IN..15.45%28 399
PHILIPS-3.22%27 463
More Results